# Connexin Therapeutics Group (Connexin Therapeutics Group Limited)

Private limited company registered in York, classed under “Research and experimental development on biotechnology”.

- Company number: 13765799
- Status: Active
- Type: Private limited company
- Incorporated: 25 November 2021
- Registered office: Kiln Lodge Malt Kiln Lane, Appleton Roebuck, York, YO23 7DT
- Location: York
- Activity: Research and experimental development on biotechnology

## Latest filed profit

No profit figure in its latest filed accounts.

Turnover, net assets, cash, staff, earlier years, ratios and owners are on the page for subscribers.

## Questions people ask

### What does Connexin Therapeutics Group do?

Private limited company registered in York, classed under “Research and experimental development on biotechnology”.

### How much turnover does Connexin Therapeutics Group make?

Answered on the page for FirmFacts Pro subscribers: https://firmfacts.co/company/connexin-therapeutics-group-13765799

### Is Connexin Therapeutics Group profitable?

Connexin Therapeutics Group's profit isn't public: small companies may file without a profit and loss account.

### Who runs and owns Connexin Therapeutics Group?

Its directors are Christopher James Hill. Its owners are shown to subscribers.

### Where is Connexin Therapeutics Group based?

Its registered office is Kiln Lodge Malt Kiln Lane, Appleton Roebuck, York, YO23 7DT, in York.

### When was Connexin Therapeutics Group founded?

Connexin Therapeutics Group Limited was incorporated on 25 November 2021.

### Is Connexin Therapeutics Group still trading?

The register lists Connexin Therapeutics Group Limited as active.

## Timeline

Recent filings and changes at Companies House.

- 2026-10-13: First Gazette notice for voluntary strike-off
- 2026-10-05: Application to strike the company off the register
- 2026-09-01: Accounts for a dormant company made up to 30 November 2025
- 2025-08-19: Accounts for a dormant company made up to 30 November 2024
- 2024-09-17: Accounts for a dormant company made up to 30 November 2023
- 2023-08-08: Accounts for a dormant company made up to 30 November 2022
- 2022-03-23: Notification of a person with significant control statement
- 2022-02-15: Cessation of Christopher James Hill as a person with significant control on 8 February 2022
- 2022-02-15: Statement of capital following an allotment of shares on 8 February 2022 · GBP 101,190
- 2022-02-14: Resolutions
- 2021-11-25: Incorporation

---

Source: Companies House filings (Open Government Licence v3.0). Figures are as filed; nothing is estimated. Page: https://firmfacts.co/company/connexin-therapeutics-group-13765799